Deoxycytidine Kinase (DCK) (Middle Region) Peptide
DCK
适用: 人
宿主: 合成
BP, WB
-
- 抗原 See all DCK products
- DCK (Deoxycytidine Kinase (DCK))
- 蛋白结构域
- Middle Region
- 宿主
- 人
-
资源
- 合成
- 应用范围
- Blocking Peptide (BP), Western Blotting (WB)
- 产品特性
- This is a synthetic peptide designed for use in combination with anti-DCK antibody (Catalog #: ARP51775_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- 纯化方法
- Purified
-
-
- 应用备注
- Each Investigator should determine their own optimal working dilution for specific applications.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- 浓度
- 1 mg/mL
- 缓冲液
- Final peptide concentration is 1 mg/mL in PBS.
- 注意事项
- Avoid repeated freeze-thaw cycles.
- 储存条件
- -20 °C
- 储存方法
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- 抗原
- DCK (Deoxycytidine Kinase (DCK))
- 别名
- dck Peptide, DCK Peptide, wu:fc15f06 Peptide, zgc:101771 Peptide, dck1 Peptide, deoxycytidine kinase Peptide, deoxycytidine kinase, gene 2 L homeolog Peptide, deoxycytidine kinase, gene 2 Peptide, Deoxycytidine kinase Peptide, deoxycytidine kinase, gene 1 L homeolog Peptide, DCK Peptide, dck Peptide, dck.2.L Peptide, dck.2 Peptide, Dck Peptide, FPV059 Peptide, FPV151 Peptide, dck.1.L Peptide
- 背景
-
Deoxycytidine kinase (DCK) is required for the phosphorylation of several deoxyribonucleosides and their nucleoside analogs. Deficiency of DCK is associated with resistance to antiviral and anticancer chemotherapeutic agents. Conversely, increased deoxycytidine kinase activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives. DCK is clinically important because of its relationship to drug resistance and sensitivity.Deoxycytidine kinase (DCK) is required for the phosphorylation of several deoxyribonucleosides and their nucleoside analogs. Deficiency of DCK is associated with resistance to antiviral and anticancer chemotherapeutic agents. Conversely, increased deoxycytidine kinase activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives. DCK is clinically important because of its relationship to drug resistance and sensitivity. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alias Symbols: MGC117410, MGC138632
Protein Interaction Partner: DDX19B,GOLM1,MED19,DDX19B,GOLM1,MED19
Protein Size: 260 - 分子量
- 30 kDa
- 基因ID
- 1633
- NCBI登录号
- NM_000788, NP_000779
- UniProt
- P27707
-
You are here:
